RankingsPricing
  1. US-listed companies
  2. CATALYST PHARMACEUTICALS, INC.
  3. Raw

CATALYST PHARMACEUTICALS, INC.CPRX

Market cap
$2.8B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Cash and cash equivalents61292814571790130171298138518
Accounts receivable, net--------1167105465
Inventory-------56,01225871620
Prepaid expenses and other current assets199,116125211248451321
Total current assets617254460418555111159210321219624
Operating Lease, Right-of-Use Asset--------793,252-3332
Property and equipment, net12,18653,67940,62871,377191,549244,204191,385245,425210,467129,8001111
Finite-Lived Intangible Assets, Net-----------32194157
Deferred tax assets, net---------3324193746
Investment in equity securities------------1622
Total assets617254460428560112192238376470851
Accounts payable263,9341850,78922933,1762244341517
Accrued Liabilities, Current569,867281,0021421272019245461104
Total current liabilities833,801226324102423275876121
Operating Lease, Liability, Noncurrent--------647,532-4433
Other non-current liabilities2498,587---------1430
Total liabilities2249524102523317582124
Preferred Stock, Value, Issued--------------
Common Stock, Value, Issued24,70141,42154,13369,11982,85182,972102,549102,739103,397103,7820000
Additional paid-in capital425776105145147207211216223233250266442
Retained earnings-38,102,617-42,179,003-54,333,599-69,842,660-90,075,618-108,148,070-126,560,447-160,563,961-128,688,624-53,705,624-2650121285
Accumulated other comprehensive income (Note 4)--------20,2489,50531,332-0000
Total stockholders' equity41521355539815188170207300388728
Total liabilities and stockholders' equity617254460428560112192238376470851